Skip to main navigation Skip to search Skip to main content

Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatin

  • Daniel D. Karp
  • , Michael N. Pollak
  • , Roger B. Cohen
  • , Peter D. Eisenberg
  • , Paul Haluska
  • , Donghua Yin
  • , Allan Lipton
  • , Laurence Demers
  • , Kim Leitzel
  • , Mary L. Hixon
  • , Leon W. Terstappen
  • , Linda Garland
  • , Luis G. Paz-Ares
  • , Felipe Cardenal
  • , Corey J. Langer
  • , Antonio Gualberto

Research output: Contribution to journal › Article › peer-review

58   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatin'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science